Related references
Note: Only part of the references are listed.Glucose homeostasis in Huntington disease - Abnormalities in insulin sensitivity and early-phase insulin secretion
Nebojsa M. Lalic et al.
ARCHIVES OF NEUROLOGY (2008)
Minireview: Obesity and lipodystrophy - Where do the circles intersect?
Farid F. Chehab
ENDOCRINOLOGY (2008)
The metabolic profile of early Huntington's disease - a combined human and transgenic mouse study
Anna O. G. Goodman et al.
EXPERIMENTAL NEUROLOGY (2008)
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells -: Possible role of peroxisome proliferator-activated receptor-γ (PPARγ) in the pathogenesis of Huntington disease
Rodrigo A. Quintanilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Adipose tissue hormones and the regulation of food intake
B. A. Henry et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Adipokines and the peripheral and neural control of energy balance
Rexford S. Ahima et al.
MOLECULAR ENDOCRINOLOGY (2008)
Increased metabolism in the R6/2 mouse model of Huntington's disease
Jorien M. M. van der Burg et al.
NEUROBIOLOGY OF DISEASE (2008)
The ratio of leptin to adiponectin can be used as an index of insulin resistance
Naohisa Oda et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
EXTENSIVE EARLY MOTOR AND NON-MOTOR BEHAVIORAL DEFICITS ARE FOLLOWED BY STRIATAL NEURONAL LOSS IN KNOCK-IN HUNTINGTON'S DISEASE MICE
M. A. Hickey et al.
NEUROSCIENCE (2008)
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies
Jeffrey N. Savas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease
Mahmoud Kiaei
PPAR RESEARCH (2008)
Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease
K. Josefsen et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Transcriptional signatures in Huntington's disease
Jang-Ho J. Cha
PROGRESS IN NEUROBIOLOGY (2007)
Leptin: Adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery
Giuseppe Danilo Norata et al.
STROKE (2007)
Leptin-to-adiponectin ratio as independent predictor of insulin sensitivity during growth in overweight Hispanic youth
C. Koebnick et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
Adipose tissue-derived factors: Impact on health and disease
Maria E. Trujillo et al.
ENDOCRINE REVIEWS (2006)
Adipocyte differentiation from the inside out
Evan D. Rosen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration
Patrick Weydt et al.
CELL METABOLISM (2006)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
Transcriptional control of adipocyte formation
Stephen R. Farmer
CELL METABOLISM (2006)
Central nervous system control of food intake and body weight
G. J. Morton et al.
NATURE (2006)
Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα regulatory pathway
Brian N. Finck et al.
CELL METABOLISM (2006)
Hypothalamic-endocrine aspects in Huntington's disease
Asa Petersen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Adipose tissue as an endocrine organ
Rexford S. Ahima
OBESITY (2006)
Metabolic consequences of lipodystrophy in mouse models
Karen Reue et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2006)
Adipose tissue - From lipid storage compartment to endocrine organ
Philipp E. Scherer
DIABETES (2006)
Mechanisms of disease: histone modifications in Huntington's disease
Ghazaleh Sadri-Vakili et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets
WG Zhai et al.
CELL (2005)
Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing
MA Hickey et al.
NEUROBIOLOGY OF DISEASE (2005)
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease
F Borovecki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression in Huntington's disease skeletal muscle: a potential biomarker
AD Strand et al.
HUMAN MOLECULAR GENETICS (2005)
Metabolic control through the PGC-1 family of transcription coactivators
JD Lin et al.
CELL METABOLISM (2005)
Adipose tissue, inflammation, and cardiovascular disease
AH Berg et al.
CIRCULATION RESEARCH (2005)
PGC-1α deficiency causes multi-system energy metabolic derangements:: Muscle dysfunction, abnormal weight control and hepatic steatosis
TC Leone et al.
PLOS BIOLOGY (2005)
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient β-cell mass and exocytosis
M Björkqvist et al.
HUMAN MOLECULAR GENETICS (2005)
Medical progress - Acquired and inherited lipodystrophies
A Garg
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Assessment of the nutrition status of patients with Huntington's disease
A Trejo et al.
NUTRITION (2004)
A cell-based screen for drugs to treat Huntington's disease
CT Aiken et al.
NEUROBIOLOGY OF DISEASE (2004)
Lipin expression preceding peroxisome proliferator-activated receptor-γ is critical for adipogenesis in vivo and in vitro
J Phan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation
RR Ribchester et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice
EA McCaw et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A
H Hu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease
V Popovic et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1α null mice
JD Lin et al.
CELL (2004)
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats
LB Menalled et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Huntington's disease of the endocrine pancreas: Insulin deficiency and diabetes mellitus due to impaired insulin gene expression
OA Andreassen et al.
NEUROBIOLOGY OF DISEASE (2002)
Weight loss in early stage of Huntington's disease
L Djoussé et al.
NEUROLOGY (2002)
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2002)
Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation
JN Fain et al.
HUMAN MOLECULAR GENETICS (2001)
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
